NCT04641676 - A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

September 15, 2022

Study Completion Date

December 31, 2022

Conditions

Metastatic CancerLocal Tumor Invasion

Interventions

DIAGNOSTIC_TEST

NGS testing

NGS test will be performed

Trial Locations (12)

1000

RECRUITING

Institute Jules Bordet, Brussels

1090

RECRUITING

AZ VUB, Brussels

1200

RECRUITING

Les Cliniques Universitaires St Luc, Brussels

2020

RECRUITING

ZNA, Antwerp

2610

NOT_YET_RECRUITING

GZA, Antwerp

2650

RECRUITING

Universitaire Ziekenhuis Antwerpen, Edegem

2930

RECRUITING

AZ Klina, Brasschaat

3500

NOT_YET_RECRUITING

Jessa Ziekenhuis, Hasselt

4000

RECRUITING

CHU Sart-Tilman, Liège

6000

RECRUITING

Grand Hôpital de Charleroi, Charleroi

9000

RECRUITING

UZ Gent, Ghent

9100

NOT_YET_RECRUITING

AZ Nikolaas, Sint-Niklaas